Bridger Management
Latest statistics and disclosures from Bridger Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UBER, GDDY, CZR, VRTX, MS, and represent 42.02% of Bridger Management's stock portfolio.
- Added to shares of these 10 stocks: PFE (+$10M), XENE (+$6.8M), SWTX, ACAD, ALNY, ATRC, CPRX, QURE, VRTX, CYTK.
- Started 9 new stock positions in ALNY, CYTK, CPRX, XENE, PFE, MSFT, ACAD, SWTX, ATRC.
- Reduced shares in these 10 stocks: MLCO (-$16M), , ALC (-$7.8M), , CHTR (-$6.8M), AKRO (-$5.1M), BLCO, UBER, SHC, .
- Sold out of its positions in AKRO, BLCO, BIIB, CRL, DXCM, IMGN, PODD, KNF, SHC, Surrozen. THC, ALC.
- Bridger Management was a net seller of stock by $-39M.
- Bridger Management has $260M in assets under management (AUM), dropping by -4.54%.
- Central Index Key (CIK): 0001166309
Tip: Access up to 7 years of quarterly data
Positions held by Bridger Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Bridger Management
Bridger Management holds 28 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Uber Technologies (UBER) | 10.6 | $27M | -12% | 445k | 61.57 |
|
Godaddy Cl A (GDDY) | 9.7 | $25M | 236k | 106.16 |
|
|
Caesars Entertainment (CZR) | 7.7 | $20M | 428k | 46.88 |
|
|
Vertex Pharmaceuticals Incorporated (VRTX) | 7.5 | $20M | +13% | 48k | 406.89 |
|
Morgan Stanley Com New (MS) | 6.5 | $17M | 182k | 93.25 |
|
|
Eli Lilly & Co. (LLY) | 6.3 | $16M | 28k | 582.92 |
|
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.0 | $16M | 1.5M | 10.44 |
|
|
Bath & Body Works In (BBWI) | 5.5 | $14M | -16% | 332k | 43.16 |
|
Us Foods Hldg Corp call (USFD) | 5.5 | $14M | 312k | 45.41 |
|
|
Endeavor Group Hldgs Cl A Com (EDR) | 4.0 | $10M | 437k | 23.73 |
|
|
Charter Communications Inc N Cl A (CHTR) | 4.0 | $10M | -39% | 27k | 388.68 |
|
Pfizer (PFE) | 3.9 | $10M | NEW | 351k | 28.79 |
|
Docebo (DCBO) | 3.6 | $9.3M | +22% | 193k | 48.38 |
|
Crown Holdings (CCK) | 3.5 | $9.1M | 99k | 92.09 |
|
|
Xenon Pharmaceuticals (XENE) | 2.6 | $6.8M | NEW | 147k | 46.06 |
|
Quanterix Ord (QTRX) | 1.6 | $4.2M | 155k | 27.34 |
|
|
Springworks Therapeutics (SWTX) | 1.4 | $3.7M | NEW | 101k | 36.50 |
|
ACADIA Pharmaceuticals (ACAD) | 1.4 | $3.7M | NEW | 117k | 31.31 |
|
Alnylam Pharmaceuticals (ALNY) | 1.4 | $3.6M | NEW | 19k | 191.41 |
|
Williams Rowland Acquisition (WRAC) | 1.2 | $3.1M | 297k | 10.48 |
|
|
AtriCure (ATRC) | 1.2 | $3.1M | NEW | 87k | 35.69 |
|
Catalyst Pharmaceutical Partners (CPRX) | 1.2 | $3.1M | NEW | 185k | 16.81 |
|
Uniqure Nv SHS (QURE) | 0.9 | $2.5M | +2917% | 362k | 6.77 |
|
Alphabet Cap Stk Cl A (GOOGL) | 0.7 | $1.9M | 14k | 139.69 |
|
|
Melco Resorts And Entmnt Adr (MLCO) | 0.7 | $1.9M | -89% | 215k | 8.87 |
|
Cytokinetics Com New (CYTK) | 0.7 | $1.9M | NEW | 23k | 83.49 |
|
Microsoft Corporation (MSFT) | 0.5 | $1.2M | NEW | 3.3k | 376.04 |
|
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $9.1k | 467k | 0.02 |
|
Past Filings by Bridger Management
SEC 13F filings are viewable for Bridger Management going back to 2010
- Bridger Management 2023 Q4 filed Feb. 14, 2024
- Bridger Management 2023 Q3 filed Nov. 14, 2023
- Bridger Management 2023 Q2 filed Aug. 14, 2023
- Bridger Management 2023 Q1 filed May 15, 2023
- Bridger Management 2022 Q4 filed Feb. 15, 2023
- Bridger Management 2022 Q3 filed Nov. 14, 2022
- Bridger Management 2022 Q2 filed Aug. 15, 2022
- Bridger Management 2022 Q1 filed May 13, 2022
- Bridger Management 2021 Q4 filed Feb. 14, 2022
- Bridger Management 2021 Q3 filed Nov. 15, 2021
- Bridger Management 2021 Q2 filed Aug. 16, 2021
- Bridger Management 2021 Q1 filed May 14, 2021
- Bridger Management 2020 Q4 filed Feb. 16, 2021
- Bridger Management 2020 Q3 filed Nov. 16, 2020
- Bridger Management 2020 Q2 filed Aug. 14, 2020
- Bridger Management 2020 Q1 filed May 15, 2020